PROGRESS STUDY: Progression of chronic kidney disease in children and heat shock proteins

Zeynep Nagehan Yuruk Yildirim1, Sebahat Usta Akgul2, Harika Alpay3

  • 1Division of Pediatric Nephrology, Istanbul Faculty of Medicine, Istanbul University, Capa, 34390, Istanbul, Turkey. znyuruk@gmail.com.

Cell Stress & Chaperones
|October 21, 2021
PubMed

Insights

Heat shock proteins (HSPs) are involved in pediatric chronic kidney disease (CKD). While initially elevated in CKD patients, HSP levels change over time and do not predict disease progression, suggesting a weakening protective role.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biochemistry

Background:

  • Renal fibrosis involves oxidative stress, inflammation, endothelial cell injury, and apoptosis.
  • Heat shock proteins (HSPs) are implicated in the progression of chronic kidney disease (CKD).

Purpose of the Study:

  • To evaluate changes in urine and serum HSP levels over time in children with CKD.
  • To assess the relationship between HSP levels and clinical parameters of CKD in pediatric patients.

Main Methods:

  • Prospective study of 117 children with CKD and 56 healthy controls over 24 months.
  • Measurement of serum and urine HSP27, HSP40, HSP47, HSP60, HSP70, HSP72, HSP90, and anti-HSP60/70 levels using ELISA at baseline, 12, and 24 months.

Main Results:

  • Elevated baseline urine HSP levels and serum HSP40, HSP47, HSP60, HSP70, anti-HSP60, and anti-HSP70 in children with CKD compared to controls.
  • Decreasing serum HSP47 and HSP60, and increasing serum HSP90 and anti-HSP60 levels over 24 months.
  • Decreasing urine HSP levels (except HSP90) over time in CKD patients.

Conclusions:

  • CKD progression is complex and involves HSPs, but they do not predict disease progression.
  • The protective role of HSPs in CKD may diminish over time.
  • HSP90 might have a detrimental effect on the course of pediatric CKD.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
167
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
124
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
217
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
159
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
156
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
209